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Purpose: To report outcomes of phakic intraocular lens (IOL) implantation after deep
anterior lamellar keratoplasty (DALK) to correct high ametropia.
Setting: Centro Hospitalar Universitário do Porto, Portugal.
Methods: Retrospective case series with 11 eyes submitted to phakic IOL implantation after
DALK. Main outcomes measured were uncorrected and corrected distance visual acuity
(UDVA and CDVA), refractive error components, tomographic parameters and endothelial
cell density (ECD). The minimum follow-up was 3 years for all cases.
Results: Mean ECD loss was 8.7±6.7% at 1 year, 13.1±8.6% at 3 years (n=11; p=0.016,
p=0.007, respectively) and 14.0±20.4% at 5 years (n=5, p=0.212). Mean logMAR UDVA
increased from 1.27±0.90logMAR preoperatively to 0.16±0.15logMAR postoperatively
(p≤0.001) and no statistically significant differences were registered during follow-up. All
patients gained at least 5 lines of UDVA. 54.5% of the eyes gained 1 line in CDVA
postoperative and only one eye lost one CDVA line through follow-up. Efficacy and safety
indexes at 1 and 3 years were 1.01–0.97 and 1.24–1.21, respectively. Mean spherical
equivalent was reduced from −7.84±4.63 D preoperatively to −1.05±1.07 D postoperatively
(p=0.001). Mean percentage of reduction in refractive cylinder and spherical error was 83.8
±15.8% and 73.1±31.5%, respectively, p≤0.001 for both. In one eye there was a significantly
gradual ECD loss over 5 years follow-up and the patient will be submitted to IOL explant.
Conclusion: Phakic IOLs were effective for correction high ametropia after DALK, show-
ing high efficacy and safety indexes with stability over time. However, it was registered a
continuing endothelial cell loss postoperatively, which assumed to be higher than those
reported in eyes without DALK.
Keywords: phakic intraocular lens, deep anterior lamellar keratoplasty, endothelial cell
density, visual outcomes, refractive outcomes
Introduction
Deep anterior lamellar keratoplasty (DALK) is the gold-standard keratoplasty tech-
nique for the treatment of keratoconus and other anterior lamellar corneal pathology
not affecting the endothelium. Risk of graft rejection, postoperative complications
and late endothelial cell density (ECD) decay is reduced when compared to tradi-
tional penetrating keratoplasty (PK). Nevertheless, differences between visual acuity,
refractive errors and corneal astigmatism following DALK or PK are similar.1–3
Postoperative uncorrected visual acuity after these procedures is often poor due
to postoperative ametropia, especially high astigmatism.4
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Several options can be considered for the management
of postoperative ametropia, ranging from conservative
solutions such as spectacles or contact lenses, to corneal
refractive surgery and intraocular surgical procedures.
The presence of anisometropia can limit the use of spec-
tacles. Rigid gas-permeable contact lenses are effective in a
high percentage of patients,5 but topographical irregularities,
dry eye, poor manual dexterity and lack of motivation make
contact lenses’ fitting a challenging process in some cases.
Corneal refractive surgery with excimer laser photorefractive
keratectomy (PRK) or LASIK can treat a great range of
postoperative refractive error by corneal tissue ablation.
However, the corneal graft thickness and the amount of
ametropia and astigmatism suitable for correction limit the
effectiveness of these procedures.
Intraocular surgical procedures with implantation of
iris-fixated phakic intraocular lenses (IOLs) or posterior
chamber IOLs6,7 can also be successfully used for surgical
correction of high post-graft ametropia.
TheArtisan® andArtiflex® lenses (OphtecBV,Groningen,
the Netherlands) are anterior chamber, iris-enclaved, phakic
IOLs. These IOLs demonstrate reversibility, high optical qual-
ity, refractive predictability and stability. Some previous
reports describe good postoperative results in the correction
of ametropias after PK and DALK with these IOLs.8–12
However, to the best of our knowledge, there are few reports
regarding long-term results of corneal ECD loss and visual and
refractive outcomes of phakic IOL implantation in patients
who had previously undergone DALK.
The aim of this study was to report the long-term
clinical outcomes of a case series of patients with phakic
IOL implantation for correction of ametropia following
DALK for keratoconus.
Methods
Study Population
Retrospective, noncomparative study with 11 eyes of 11
patients with keratoconus who underwent DALK with the
big-bubble technique from February 2009 to June 2012 at
Centro Hospitalar Universitário do Porto, Portugal. The
patients were subsequently submitted to toric phakic IOL
implantation for correction of ametropia.
All surgeries were performed by 2 surgeons, L.O andM.G,
with extensive experience in the implantation of phakic IOLs.
Before phakic IOL implantation, the patients under-
went routine ophthalmic examination, including manifest
and cycloplegic refractions, evaluation of uncorrected dis-
tance visual acuity (UDVA) and distance corrected visual
acuity (CDVA), slit-lamp examination, Goldmann appla-
nation tonometry, gonioscopy, dilated fundus examination,
corneal tomography and endothelial cell count.
Preoperatively, all the patients showed corneal graft
transparency, normal status of the crystalline, anterior
chamber depth (ACD) equal to or higher than 3.20 mm,
endothelial cell count higher than 1500 cells/mm2 and a
stable refractive status for at least 18 months. Table 1
summarizes the patients’ details at baseline.
None of the patients had a history of recurrent or
chronic uveitis, glaucoma, retinal pathologies or neurolo-
gical eye diseases which could affect visual acuity.
This study was in accordance with the ethical princi-
ples for medical research involving human subjects
Table 1 Preoperative Parameters Of The Study Population
Patient Age At The Time Of
IOL Implantation
(Years)
Time Between DALK
And IOL Implantation
(Months)
Preoperative
Subjective
Refraction (D)
Preoperative ECD
(Cells/mm2)
Preoperative
ACD (mm)
1 26 314 −5.0–4.5×170° 2674 3.59
2 27 25.9 −13.0–2.0×150° 2404 3.75
3 37 34.6 +2.5–6.5×10° 1515 3.20
4 34 42.0 −6.0×30° 2320 3.25
5 36 63.3 −7.5–10.0×145° 2915 3.70
6 42 39.3 −8.0–10.0×90° 1835 4.11
7 24 30.6 −4.0–5.0×55° 1800 3.83
8 18 30.2 −7.0–7.0×145° 2703 3.88
9 35 29.6 −1.0–8.5×50° 2250 3.31
10 23 35.9 −5.5–11.0×10° 2994 3.70
11 26 29.4 +3.0–11.0×105° 2088 3.74
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(Helsinki Declaration) and was approved by the local
ethics committee of Centro Hospitalar Universitário do
Porto. Informed consent was obtained from each patient
prior to surgical procedure.
Outcomes Measures
The main outcomes measures were UDVA, CDVA with
manifest refraction, refractive sphere, refractive cylinder,
refractive spherical equivalent (SE), topographic astigma-
tism, corneal thickness, ACD and corneal ECD. Calculation
of safety index (mean postoperative CDVA/mean preopera-
tive CDVA) and efficacy index (mean postoperative UDVA/
mean preoperative CDVA) of the procedure was conducted.
The incidence of intraoperative and postoperative com-
plications of phakic IOLs implantation was also assessed.
For the current study, the outcomes were analysed pre-
operatively and at 1 and 3 years after surgery for all the
patients (n=11). In 5 patients, with a longer follow-up, the
analysis was extended to 5 years after IOL implantation.
Corneal ECD was measured using specular microscope
(Konan® Noncon Robo CA SP-8800) and the percentage of
ECD loss per year was calculated. Topographic astigmatism,
corneal thickness and ACD were measured using corneal
Scheimpflug imaging (Oculus Wavelight Pentacam®).
Phakic IOLs Implanted
The Artisan® phakic toric IOL (Ophtec BV, Groningen,
the Netherlands) has a convex–concave toric optic. It is a
single-piece lens with an overall size of 8.5 mm and is
composed of polymethyl methacrylate (PMMA). It is iris-
claw fixated and has a 5-mm optical zone. The IOL is
available in dioptric powers of −1.0 to −23.5 and +1.0 to
+12.0 and in cylindrical powers of −1.0 to −7.5 D. The
Artifex® phakic toric IOL (Ophtec BV, Groningen, the
Netherlands) is a foldable version of the Artisan® phakic
IOL made of three pieces: a 6.0 mm similar convex–
concave optic zone design, made of hydrophobic polysili-
con, and two opposed haptics made of PMMA to enable
fixation on the mid-peripheral iris. Overall length is 8 mm.
The IOL is available in dioptric powers of −1.0 to −14.5 D
and in cylindrical powers of −1.0 to −5.0 D.
The Artisan® phakic IOL was used when the refractive
error could not be fully corrected by the Artiflex® lens.
The power calculation of the phakic IOL was obtained
by Ophtec BV and approved by the surgeon. Refractive
spherical error, refractive cylinder power, ACD and topo-
graphically derived keratometric dioptric values were
inserted into the van der Heijde formula to calculate the
dioptric power of the lens.
Surgical Technique
Previously to surgery, an iridectomy was made by a neo-
dymium:YAG laser in all the eyes.
All surgeries were performed under general anesthesia.
Pupils were constricted with pilocarpine 2% before surgery
and the enclavation meridian was marked at the slit-lamp
with a needle to avoid misalignments in relation to the
cyclotorsion. For Artisan® lens, a 5mm length clear corneal
incision was created perpendicular to the axis of lens encla-
vation, followed by two stab incisions located close to the
clear corneal incision, directed toward the enclavation sites.
For Artiflex® lens it was used a clear corneal incision of
3.2mm. The anterior chamber was filled with viscoelastic
(Provisc, Alcon Laboratories, Inc., Fort Worth, TX) and the
lenses were slid into the anterior chamber, using a lens’
forceps for Artisan® and a specially designed insertion spa-
tula for Artiflex® (Operaid Artiflex® Implantation Spatula;
Ophtec). Viscoelastic was re-injected and the lenses were
placed in its proper position using a manipulator and fixed
to themid-peripheral iris with the enclavation needle, accord-
ing to the alignment marks on the cornea. After, the viscoe-
lastic was changed with balanced salt solution. Finally, the
clear corneal incision was closed with 10–0 nylon sutures
and it was injected 1 mg/0.1 mL of cefuroxime sodium in the
anterior chamber.
Postoperative care consisted of topical dexamethasone
0.2% 5 times a day tapered in 3weeks, topical fluoroquinolone
5 times a day for 2 weeks, topical nonsteroidal anti-inflamma-
tory 5 times a day for 4weeks and oral prednisolone 1mg/kg in
a defined tapering scheme during 2 weeks.
Statistical Analysis
UDVA and CDVA were recorded on a decimal scale and
converted into logarithm of the minimum angle of resolu-
tion (logMAR) values to statistical analysis. The efficacy
and safety indexes were calculated using a mean value
expressed on decimal scale, before conversion. Statistical
analysis was done using SPSS (version 24; SPSS Inc.,
Chicago, IL, USA). After checking the normality of data
using the Shapiro–Wilk test, the Student’s t-test for paired
samples was used to compare preoperative and postopera-
tive data when parametric analysis could be applied, and to
compare it between consecutive postoperative visits.
When non-parametric tests were required, the Wilcoxon
ranked-sum test was used. Changes in corneal thickness,
Dovepress Malheiro et al
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ACD and topographic astigmatism during follow-up were
compared using repeated-measures two-way analysis of
variance with Bonferroni correction. A p-value of less
than 0.05 was considered statistically significant. All data
were expressed as mean±SD.
Results
Patient Population
The study included 11 eyes of 11 patients (4 female, 7 male)
with a mean age of 29±7 years (range 17 to 42 years).
The mean time between DALK and toric phakic IOL
implantation was 35.7±10.3 months (range 25.9 to 63.2
months). All sutures were removed before IOL implanta-
tion. The refractive status was stable for at least 18 months
before IOL implantation. The toric Artisan lens was
implanted in 8 eyes (73%) and the toric Artiflex lens in
3 eyes (27%). All patients had a minimum follow-up of 3
years after IOL implantation. In 5 patients, the analysis of
the outcomes was extended up to 5 years after IOL
implantation (3 eyes with Artisan lens and 2 eyes with
Artiflex lens). Figure 1 illustrates one of the eyes with an
Artisan IOL at 1-year follow-up.
Visual Acuity
The mean logMAR UDVA and CDVA significantly increased
from preoperative to 1 year postoperative (n=11, p≤0.001 for
UDVA and p=0.008), as shown in Table 2.
During follow-up, no statistically significant differ-
ences were registered in UDVA and CDVA comparing to
the values registered at 1 year postoperative (p>0.05, for
all comparisons, Table 2). Postoperatively, all patients
gained at least 5 lines in UDVA (7.18±2.09 lines) and
63.6% of the eyes gained 2 or more lines in CDVA
(Figures 2 and 3). During follow-up, only one eye lost 1
line in CDVA.
At 1 year of follow-up, 100% of the eyes had an
UDVA equal or better than 0.30 logMAR, and 45.5% an
UDVA equal or better than 0.10 logMAR, as compared
with 0% preoperatively. At 3 years postoperative, an
UDVA and a CDVA equal or better than 0.1 logMAR
was registered in 45.4% and 81.8% of eyes, respectively.
The calculated efficacy index was 1.01, 0.97 and 1.02 at
1, 3 and 5 years postoperatively, respectively. The calcu-
lated safety index was 1.24, 1.21 and 1.26 at 1, 3 and 5
years, respectively.
Refractive Outcome
The mean sphere decreased from −4.14±4.87 D (range
−13.00 to +3.00 D) preoperative to −0.55±0.82 D (range
−1.75 to +1.00 D) at 1 year postoperative (n=11, p= 0.033)
and no statistically significant differences were registered
during follow-up visits (n=11, p= 0.614 for 3 years follow-
up; n=5, p=0.847 for 5 years follow-up). The percentage of
reduction in spherical error was 73.1±31.5%.
Mean refractive cylinder significantly decreased from
−7.41±3.61 D (range −11.00 to −2.00 D) preoperative to
−1.00±0.95 D (range −2.50 to 0.0 D) at 1 year postopera-
tive (n=11, p≤0.001). The mean percent reduction in
refractive astigmatism was 83.8±15.8%. No significant
changes were observed in refractive cylinder during fol-
low-up (Table 2). The distribution of the postoperative
refractive astigmatism achieved is shown in Figure 4. At
3 years, the refractive cylinder was within ±1.00 D in
45.4% of eyes and within ±2.00 D in 81.8% of eyes.
The mean SE refraction decreased from −8.02±4.63 D
(range −0.75 to −14.00 D) preoperative to −1.02±1.07 D
(range 0.0 to −2.50 D) at 1 year postoperative (n=11,
p=0.001). Figure 5 shows the SE accuracy 1 year after
the procedure and Figure 6 illustrates the stability of SE
during 3 years follow-up.
At 3 years, mean SE refraction was within ±0.50 D in
45.4% of eyes and within ±1.50 D in 63.6% of eyes.
Table 3 resumes the visual and refractive data of eyes
submitted to Artisan and Artiflex IOLs implantation at 3
years follow-up.
Endothelial Cell Count
The endothelial cell loss, as compared with preoperative,
was 8.7±6.7% (n=11), 13.1±8.6% (n=11) and 14.0±20.4%
Figure 1 Postoperative slit-lamp photograph 1 year after toric Artisan phakic
intraocular lens implantation in eye with previous DALK.
Malheiro et al Dovepress
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(n=5) at 1 year (p=0.020), 3 years (p=0.007) and 5 years
postoperatively (p=0.137), respectively.
It was registered a progressive decrease in ECD over
time in operated eyes. The decline in ECD between 1 to 3
years and 3 to 5 years of follow-up was not statistically
significant (Table 2).
Corneal Thickness, ACD And
Topographic Astigmatism
There were no statistically significant differences in cor-
neal thickness, ACD and topographic astigmatism over
time (Table 4).
Intraoperative And Postoperative
Complications Of TICL Implantation
No severe intraoperative complications were registered.
None of the eyes included developed ocular hypertension,
pupillary block, acute angle-closure glaucoma or episodes of
graft rejection. One of the patients (patient 3, male, 37 years
old at the time of IOL implantation) had registered an impor-
tant decrease in ECD and ACD over the 5 years’ follow-up.
This patient had the lowest ECD and ACD preoperatively.
Before Artisan Iens implantation, the ECD was 1515 cells/
mm2 andACDwas 3.20mm.One year after surgery, the ECD
had decreased to 1001 cells/mm2. At this time, the patient
was proposed to IOL explantation but had refused the inter-
vention. The patient was clarified about the risk of endothe-
lial decompensation and advised not to rub the eye. Two
years after surgery, the ECD decreased to 851 cells/mm2
Table 2 Mean Preoperative And 1, 3 And 5 Years Postoperative Results Of Toric Phakic IOL Implantation After DALK: Comparative
Analysis
Outcomes UDVA CDVA Refractive Cylinder ECD (Cells/mm2)
Mean±SD p-Value Mean±SD p-Value Mean±SD p-Value Mean±SD p-Value
Preoperative vs 1 year
postoperative (n=11)
1.27±0.90 vs
0.16±0.15
≤0.001 0.16±0.14 vs
0.07±0.09
0.008 −7.41±3.61 vs
−1.00±0.95
≤0.001 2318±457 vs
2108±547
0.020
Preoperative vs 3 year
postoperative (n=11)
1.27±0.90 vs
0.22±0.17
≤0.001 0.16±0.14 vs
0.08±0.10
0.011 −7.41±3.61 vs
−1.63±0.90
≤0.001 2318±457 vs
1961±574
0.007
Preoperative vs 5 year
postoperative (n=5)
1.30±0.0 vs
0.12±0.11
≤0.001 0.14±0.09 vs
0.02±0.04
0.033 −6.75±2.04 vs
−0.85±0.49
≤0.001 2105±438 vs
1768±548
0.137
1 year postoperative vs 3
years postoperative (n=11)
0.16±0.15 vs
0.22±0.17
0.364 0.07±0.09 vs
0.08±0.10
0.341 −1.00±0.95 vs
−1.63±0.90
0.006 2108±547 vs
1961±574
0.523
1 year postoperative vs 5
years postoperative (n=5)
0.16±0.21 vs
0.12±0.11
0.757 0.02±0.04 vs
0.03±0.07
0.945 −0.37±0.40 vs
−0.85±0.49
0.102 2018±180 vs
1768±548
0.090
3 years postoperative vs 5
years postoperative (n=5)
0.14±0.09 vs
0.12±0.11
0.317 0.04±0.05 vs
0.03±0.07
0.317 −0.83±0.44 vs
−0.85±0.49
0.921 1840±591 vs
1768±548
0.255
Note: Significant values are shown in bold.
Figure 2 Cumulative uncorrected distance visual acuity 1 year after surgery (n=11).
Figure 3 Change in corrected distance visual acuity 1 year after surgery (n=11).
Dovepress Malheiro et al
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and at 3 years follow-up, it was registered an ECD of 840
cells/mm2 and an ACD of 2.94 mm. During this time, the
patient continued refusing explantation of the IOL, so was
kept in close monitoring and aware of the risk of sudden
endothelial decompensation. At the last appointment, it was
recorded an ECD of 835 cells/mm2 and an ACD of 2.91 mm.
The patient maintained a transparent graft and an UDVA of
0.0 logMAR, though will be soon submitted to IOL explan-
tation combined with phacoemulsification cataract surgery
with toric IOL implantation in the capsular bag.
Figure 4 Preoperative and 1 year postoperative refractive cylinder (n=11) in diopters.
Figure 5 Spherical equivalent refractive accuracy 1 year after surgery (n=11).
Malheiro et al Dovepress
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Discussion
Several surgical options to correct refractive errors after
DALK have been reported in the literature, such as
PRK,13,14 LASIK,15,16 small incision lenticule extraction17
and corneal relaxing incisions.18 In addition, phakic IOLs
implantation have also been satisfactorily used for visual
rehabilitation after DALK in more recent reports.7,10–12
Tiveron et al12 reported the efficacy of toric phakic IOLs
after DALK in 24 eyes (17 with implantation of Artiflex lens
and 7 with Artisan lens) with a follow-up of 1 year.
Comparing to this study, we obtained a higher safety and
efficacy indexes (1.24 vs 1.00 and 1.01 vs 0.93, respectively)
at 1 year. Moreover, in our case series the values of these
indexes slightly decreased during 3 and 5 years of follow-up,
so these IOLs proved to be a safety and effective procedure
for visual rehabilitation with stability over time.
The first two case reports of implantation of Artisan IOL
to correct ametropia10 and high astigmatism after DALK11
revealed a significant improvement in UDVA postopera-
tively, with all the 3 patients showing an UDVA and a
CDVA of 0.1 logMAR or better at 1 year of follow-up. In
this current study, the 11 patients gained at least 5 lines of
UDVA postoperatively, 63.6% of the eyes improved two or
more lines in CDVA at 1 year of follow-up and only one eye
lost one line in CDVA throughout follow-up.
Acar et al15 also described a significant improvement
in UDVA with LASIK after DALK, without eyes losing
CDVA lines. Recently, Sorkin et al14 reported a significant
improvement in CDVA and UDVA in 34 eyes submitted to
PRK postkeratoplasty. Comparing to phakic IOLs, corneal
ablation procedures carry a relatively high rate of
Figure 6 Stability of spherical equivalent during follow-up.
Table 3 Visual And Refractive Outcomes At 3 Years Follow-Up
Patient Pre-UDVA
(logMAR)
Pre-BDVA
(logMAR)
Preoperative
Refraction (D)
Type Of Toric
Phakic IOL
Implanted
3 Years Post-
UDVA
(logMAR)
3 Years Post-
BDVA
(logMAR)
3 Years
Postoperative
Refraction (D)
1 1.30 0.20 −5.0–4.5×170° Artiflex 0.30 0.10 −0.75–2.50×100°
2 1.30 0.00 −13.0–2.0×150° Artisan 0.00 0.00 −0.50×170°
3 1.30 0.00 +2.5–6.5×10° Artisan 0.00 0.00 −0.50×20°
4 1.30 0.10 −6.0×30° Artisan 0.20 0.10 −1.00–2.00×110°
5 1.30 0.20 −7.5–10.0×145° Artisan 0.20 0.10 −2.00–2.00×55°
6 1.30 0.50 −8.0–10.0×90° Artisan 0.50 0.30 −1.00–1.00×70°
7 1.30 0.20 −4.0–5.0×55° Artiflex 0.20 0.00 −1.50×35°
8 1.30 0.20 −7.0–7.0×145° Artiflex 0.20 0.10 −1.25×110°
9 1.30 0.20 −1.0–8.5×50° Artisan 0.20 0.00 −1.00–0.50×40°
10 1.30 0.00 −5.5–11.0×10° Artisan 0.50 0.00 −3.00–0.75×0°
11 1.00 0.20 +3.0–11.0×105° Artisan 0.20 0.10 +1.00–2.50×100°
Table 4 Differences In Corneal Thickness, Anterior Chamber Depth And Topographic Astigmatism During Follow-Up
Preoperative 1 Year (n=11) 3 Years (n=11) 5 Years (n=5) p-Value 3 Years
Follow-Up (n=11)
p-Value 5 Years
Follow-Up (n=5)
Corneal thickness (um) 518±56.1 515±48.2 507±52.8 536±22.3 0.661 0.847
ACD (mm) 3.62±0.33 3.53±0.35 3.48±0.26 3.48±0.41 0.154 0.528
Topographic
astigmatism (D)
6.82±2.70 5.88±3.49 5.49±3.95 5.24±2.10 0.387 0.089
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complications, such as corneal graft haze and regression of
treatment, offer less predictable results and may not fully
correct large degrees of spherical and astigmatic refractive
errors.8,19–23
The magnitude of the baseline spherical error (range +3.0
to −13.0 D) and cylindrical error (range −2.0 to −11.0 D) of
this case series reflect the wide field of power range provided
by phakic IOLs. These baseline refractive values were much
higher than those revealed in most of the reports of LASIK
postkeratoplasty, including DALK.15,16 Moreover, the per-
centage of reduction in refractive astigmatism (83.8±15.8%)
was higher when compared to LASIK after keratoplastly,
which varies from 48% to 88% in different reports of the
literature.19–24
Concerning stability of the surgical procedure, there
were no significant changes in refractive spherical, cylinder
and SE values from 1 to 3 years and 5 years of follow-up.
Also in a prospective noncomparative study with Artisan
toric IOL implantation for the correction of astigmatism and
anisometropia after PK, Tahzib et al8 revealed a reduction in
the refractive cylinder and sphere of 88.8±29.5% and
103.6%±33.0, respectively, with the stability of the values
achieved from 6 months postoperatively to 3 years of fol-
low-up.
In this case series we presented an ECD loss of 8.7±6.7%
(n=11), 13.1±8.6% (n=11) and 14.0±20.4% (n=5) (p=0.137)
at 1, 3 and 5 years of follow-up, respectively. The percentage
of ECD loss at 1 year was slightly higher than the published
by Tiveron et al.12 However, these results were favorable
when compared to those reported by Tahzib et al8 in eyes
with Artisan IOL after PK (Table 5). This could be explained
by the fact that ECD decay is higher after PK comparing to
DALK, as shown in several studies comparing both
techniques.2,3,25 In our center, the mean ECD loss after
DALK was 5.3%±4.8% at 1 year after surgery. Comparing
to eyes without keratoplasty, the ECD loss in the current
series is higher than the revealed by other studies for
Artisan26–28 and Artiflex IOLs29,30 (Table 5).
Despite our small sample size, we observed a progres-
sive endothelial cell loss at each time point as compared
with preoperative cell density values. The observed mean
ECD loss could be explained by the lens itself, by the
normal ECD loss after DALK or by the combination of
both. Nevertheless, it was not registered a significantly
loss between 1 year postoperatively to 3 and 5 years. It
is consistent with other reports which describe a more
significant decline in ECD during the first 12–24 months
after phakic IOLs implantation.31,32
In this case series, there was one patient who revealed
a significant decrease in ECD and ACD over time, reach-
ing values lower than 1000 cells/mm2 and 3.00 mm,
respectively. It should be noted that the preoperative
Table 5 Summary Of Authors And Their Study’ Results For ECD Loss After Keratoplasty And After Phakic IOLs Implantation In Eyes
With And Without Keratoplasty
Author, Year Technique Sample Size
(n= Eyes)
Country ECD Loss
Tiveron et al,12 2017 Artisan and Artiflex IOLs after DALK 24 Spain 1 year: 6.10%
Tahzib et al,8 2006 Artisan IOL after PK 34 The Netherlands 1 year: 21.2% (n=34)
3 years: 30.4% (n=18)
Cheng,25 2011 PK vs DALK 56 The Netherlands 1 year: 27.7% PK vs 12.9% DALK
Pop,26 2004 Artisan IOL without keratoplasty 765 Canada 1 year: 0.87%
Hashemi,27 2013 Artisan IOL without keratoplasty 53 Iran 1 year: 3.04%
Silva,28 2008 Artisan IOL without keratoplasty 26 USA 5 years: 14.0%
Guerin et al,29 2014 Artiflex IOL without keratoplasty 28 Ireland 1 year: 6.17%
Jonker,30 2018 Artiflex IOL without keratoplasty 188 The Netherlands 5 years: 10.2%
Our Center, 2018 DALK 47 Portugal 1 year: 5.3%
Current study, 2019 Toric phakic IOLs after DALK 11 Portugal 1 year: 8.7% (n=11)
3 years: 13.1% (n=11)
5 years: 14.0% (n=5)
Malheiro et al Dovepress
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values of ECD and ACD of this patient were the lowest of
the sample. The decision to implant phakic IOLs in
patients with preoperative endothelial cell counts lower
than those recommended by Ophtec BV is based on the
fact that, for these patients, with low BCVA due to high
ametropias after corneal transplantation, the implantation
of phakic IOLs is not considered a premium refractive
surgery. Instead, the main purpose of the procedure is to
try to provide a better visual acuity in patients who had
already tried other less invasive refractive options, without
success. This decision is made together with the patient
after carefully explaining and discussing all the complica-
tions of the surgery.
The patient will be submitted to IOL explantation
combined with cataract surgery, that, still, highlights one
of the advantages of phakic IOLs implantation, which is
the reversibility of the procedure, in contrast to corneal
ablation procedures.
To the best of our knowledge, this is the first case
series describing long-term results of toric phakic IOLs
after DALK. We demonstrate that these IOLs are an effec-
tive and stable procedure for management high ametropia
after DALK. However, we observed a continuing endothe-
lial cell loss postoperatively, which assumed to be higher
than those reported in eyes with phakic IOLs implantation
without DALK. Additional long-term analysis with larger
samples are needed to confirm these results and for them
to be used as guidance for clinical practice.
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